Bell Biosystems, Inc. — Form D/A
Bell Biosystems, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2015-04-13. The offering totals $3.8M, of which $3.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-04-13
- Form: D/A
- Accession: 0001550379-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.8M
- Amount sold: $3.8M
- Investors: 25
- Date of first sale: 2013-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209484
Issuer
- Name: Bell Biosystems, Inc.
- CIK: 0001550379
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: (703) 343-6477
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Stuart B Berman | Director | San Francisco, CA |
| Bell, III B Caleb | Director | San Francisco, CA |
| Christian B Olgaard | Director | San Francisco, CA |
| Una B Ryan | Director | San Francisco, CA |
| Gil B Van Bokkelen | Director | San Francisco, CA |
| Daniel B Bell | Executive Officer | San Francisco, CA |
| Bell, III B Caleb | Executive Officer | San Francisco, CA |
| Daniel B Bell | Director | San Francisco, CA |
| Bell B Caleb | Director | Sunnyvale, CA |
| Bell B Caleb | Executive Officer | Sunnyvale, CA |
| Caleb B Bell | Director | Sunnyvale, CA |
| Caleb B Bell | Executive Officer | Sunnyvale, CA |
Other filings by this issuer (3)
More